Taken together, Hsp90 contributes to inflammation and SLE progression, and therefore, targeting of its expression/activity may be a viable treatment for SLE [60,61,62,63,94,95,96,97,98,99,100]. The gene discussed is HSP90AB1; the disease is systemic lupus erythematosus.